1. Can You Support Healthy Blood Sugar Naturally Without Medication?

Yes, certain dietary, lifestyle, and supplement strategies have meaningful clinical evidence behind them for supporting healthy glucose metabolism. Berberine, in particular, has been studied extensively in adults with prediabetes and type 2 diabetes, with consistent effects on fasting blood glucose, postprandial glucose, and HbA1c documented across multiple randomized controlled trials. Dietary patterns that prioritize fermentable fiber, adequate protein, and low glycemic load foods also produce measurable improvements in glucose response over time. That said, these approaches work best as part of a broader metabolic health strategy — they are not a replacement for prescribed medications in people who need them, and anyone managing a diagnosed blood sugar condition should work with their healthcare provider before making changes.

2. Who Should Talk to a Doctor Before Trying Berberine or a Blood Sugar Support Supplement?

Anyone currently taking a prescription medication for diabetes, heart conditions, thyroid function, or psychiatric health should speak with their doctor before starting berberine, because it can affect how those drugs are metabolized and may amplify or interfere with their effects. People who take blood thinners, immunosuppressants, or any medication with a narrow dosing window are also in this category. Pregnant women, those who are breastfeeding, and anyone trying to conceive should avoid berberine without explicit medical guidance, as safety data in those populations is insufficient. If you are unsure whether any of your current medications interact with berberine, your pharmacist is an excellent first resource — they can review your full medication list and flag any concerns before you start.

3. How Long Does It Take to See Results From Berberine or Dietary Changes for Blood Sugar?

Most clinical trials measuring blood sugar outcomes report statistically meaningful changes within 8 to 12 weeks of consistent daily use at an effective dose. Some individuals notice subjective improvements — like feeling fewer energy crashes after meals or reduced cravings — within the first two to four weeks, though these early changes reflect metabolic shifts that precede what shows up on lab work. HbA1c, which reflects average blood sugar over approximately three months, will not meaningfully change on shorter timelines regardless of what intervention is used. Results are cumulative and require sustained daily habits, not occasional use — skipping doses or reverting to high-glycemic eating patterns will slow or erase progress.

4. Does Blood Sugar Support Only Matter if You Have Diabetes?

No, blood sugar regulation affects everyone, and the research on glucose variability increasingly shows that even people without a diabetes diagnosis can experience meaningful health effects from how their blood sugar rises and falls throughout the day. Sustained high postprandial glucose spikes, poor insulin sensitivity, and chronically elevated fasting glucose are associated with fatigue, cognitive fog, increased hunger, weight gain, and long-term cardiovascular and metabolic risk — all of which can be present well before a clinical diagnosis. The dietary and supplement strategies studied for glucose support, including fiber intake, meal timing, and berberine, have documented benefits in metabolically healthy adults as well as those with identified dysfunction. Supporting stable blood sugar is relevant to metabolic wellness broadly, not only to disease management.

5. What Foods and Nutrients Are Most Studied for Blood Sugar and Glucose Balance?

Fermentable dietary fibers — including beta-glucan from oats, resistant starch from legumes and cooked-and-cooled starchy foods, and inulin from onion, garlic, and chicory — have consistent clinical evidence for reducing postprandial glucose spikes and improving insulin sensitivity over time. Protein, particularly at breakfast and earlier in the day, has been shown to blunt glucose response and support satiety signaling that helps regulate overall intake. Berberine is the most studied botanical compound in this category, with a well-characterized mechanism of action via AMPK activation that parallels some pharmaceutical approaches. Meal sequencing — eating vegetables and protein before carbohydrates — has emerging evidence for reducing the glucose peak from a given meal without changing what you eat. No single food acts as a fix; the pattern of eating across the day matters more than any individual item.

6. Does Blood Sugar Support Work the Same Way for Everyone?

No, and this is one of the most important things the research makes clear. Individual response to both dietary interventions and berberine supplementation varies substantially based on baseline gut microbiome composition, existing insulin sensitivity, genetics, body weight, sleep quality, stress levels, and what other medications a person is taking. People with more significant metabolic dysfunction at baseline — higher fasting glucose, more pronounced insulin resistance — tend to show larger and more consistent effects in clinical trials, while those who are metabolically healthy may see subtler changes. This biological variability is normal and does not mean an approach is failing; it means the intervention needs to be evaluated in the context of the individual. Working with a clinician who can track relevant biomarkers over time is the most reliable way to assess whether a given strategy is actually working for you.

THE WELLNEST • Research • Glucose Levels

Berberine, Where Does it Come From and What is Its Most Widely Studied Source?

By Brooke Danielson

Share this research

Email Copy Link

Scientifically Reviewed By

Jennifer Martin-Biggers, PhD, MS, RDN

Registered Dietitian Nutritionist

What is What Is Berberine And Where Does It Come From? ?

Berberine is a nonbasic and quaternary benzylisoquinoline alkaloid, a relevant molecule in pharmacology and medicinal chemistry. It is found in a variety of plants like goldenseal, barberry, Oregon grape, and more.

What the research shows

Berberine has been used in traditional medicine across Ayurvedic, Chinese, and Middle Eastern systems for more than 3,000 years, with consistent historical application to metabolic conditions including diabetes, obesity, and digestive disorders, establishing a long-studied foundation for modern investigation The compound exerts pharmacological activity across multiple organ systems, with clinical and experimental studies documenting immunomodulatory, antioxidative, cardioprotective, hepatoprotective, and renoprotective effects.
Berberine's primary mechanism of metabolic action operates via AMPK (AMP-activated protein kinase) activation, the same cellular energy-sensing pathway targeted by metformin, influencing glucose uptake, lipid metabolism, and insulin sensitivity at the cellular level Individual bioavailability varies substantially due to berberine's low oral absorption and rapid metabolism; effective clinical dosing typically ranges from 900–1,500mg daily, often divided into three doses with meals to optimize absorption Evidence level: Moderate (broad review synthesizing experimental and observational data; clinical RCT evidence on metabolic outcomes is cited within, not generated by, this paper)

Evidence level: High Evidence

Appropriate for

Adults with prediabetes or mildly elevated fasting blood sugar who want to explore dietary supplement support alongside lifestyle changes
Adults with elevated LDL cholesterol or triglycerides who are interested in a plant-based metabolic support option and are not currently on prescription lipid-lowering therapy
Generally healthy adults focused on blood sugar and metabolic wellness who are not taking medications that affect glucose metabolism or drug absorption

Requires medical consultation:

Anyone currently taking diabetes medications, including metformin, insulin, or sulfonylureas — berberine has glucose-lowering effects that can compound medication action and increase hypoglycemia risk
Anyone on prescription medications for heart conditions, thyroid function, or antibiotics — berberine may slow intestinal absorption, affecting how these drugs are taken up by the body
Anyone who is pregnant, breastfeeding, or trying to conceive — safety data in these populations is insufficient, and berberine has not been evaluated for use during pregnancy

Research timeline & expectations

Typical study duration: 8–16 weeks
Observable changes: : Most clinical trials measuring glucose, lipid, and metabolic markers report measurable shifts within 8–12 weeks of consistent daily use at a dose of 900–1,500mg, divided across two to three servings with meals
Effect magnitude: Moderate: Research shows meaningful improvements in fasting blood glucose, HbA1c, and lipid panels in adults with metabolic dysfunction, but effects are notably smaller than those produced by prescription medications. Berberine is not a clinical substitute for pharmacological treatment and should not be framed or used as one Context dependency: Results are most consistent in adults who already have some degree of metabolic imbalance — elevated blood sugar, insulin resistance, or dyslipidemia. Effects in metabolically healthy adults are less well-studied. Foundational habits — including a fiber-rich diet, regular movement, and adequate sleep — appear to support outcomes, as berberine's primary mechanism (AMPK activation) works in concert with the same cellular pathways that diet and exercise engage
Primary evidence base: : his analysis draws on findings from approximately 27 peer-reviewed studies, including multiple randomized controlled trials and 3 systematic reviews or meta-analyses, published across Molecules, Frontiers in Pharmacology, and other PubMed-indexed journals. Supporting context sourced from NIH LiverTox (NBK564659), the National Center for Complementary and Integrative Health, UCLA Health, Mayo Clinic, and Memorial Sloan Kettering Cancer Center. Active clinical trials registered at ClinicalTrials.gov (NCT03438292, NCT06863922). DOI-linked references available below.

What Science Says About Berberine:

Berberine is a quaternary plant alkaloid found in several botanical sources including barberry, goldenseal, and Oregon grape, and it has been studied extensively for its effects on glucose metabolism, insulin sensitivity, and lipid regulation. Unlike most dietary supplements, berberine has a well-characterized mechanism of action: it activates AMP-activated protein kinase (AMPK), a key cellular enzyme that regulates how the body processes glucose and fat at the molecular level. Research across dozens of clinical trials and reviews has documented consistent effects on fasting blood sugar, HbA1c, and cholesterol in adults with metabolic dysfunction — making it one of the more rigorously studied botanical compounds in this category.

Primary Functions: Activates AMPK in liver, muscle, and fat tissue, which improves the body’s ability to take up and use glucose and reduces the liver’s tendency to overproduce it Reduces fasting blood glucose and postprandial (post-meal) blood sugar spikes by enhancing insulin secretion and improving insulin sensitivity at the cellular level Lowers LDL cholesterol and triglycerides by inhibiting lipid synthesis pathways in the liver and modulating fat cell development (adipogenesis) Reduces systemic inflammation by suppressing the expression of COX-2 and prostaglandin E2, inflammatory mediators that are elevated in metabolic syndrome and type 2 diabetes

Key Dietary or Lifestyle Modulators

The metabolic conditions berberine is most studied for — elevated blood sugar, insulin resistance, and dyslipidemia — are themselves worsened by poor diet quality, physical inactivity, excess body weight, chronic stress, and disrupted sleep. Berberine’s effects are most consistently demonstrated in people who already have some degree of metabolic dysfunction; the same foundational lifestyle factors that drive that dysfunction will either support or undermine what berberine can do.

Biological Mechanism

Berberine’s primary action runs through AMPK — a cellular energy sensor that, when activated, signals the body to shift from energy storage mode into energy utilization mode, improving glucose uptake in muscle, reducing glucose production in the liver, and decreasing fat accumulation in metabolically active tissues. Understanding this cascade explains both berberine’s documented effects and its natural limits.

Berberine (AMPK Activation)

Evidence grade: High Evidence

Mechanism: Berberine activates AMP-activated protein kinase (AMPK), a cellular energy-sensing enzyme that functions similarly to a metabolic switch. When AMPK is turned on, the liver reduces its output of new glucose (gluconeogenesis), muscle tissue increases glucose uptake, and fat cell development slows. Berberine also stimulates glycolysis — the process by which cells break down glucose for energy — and improves insulin receptor sensitivity, meaning cells respond more effectively to the insulin already present in the bloodstream.

Clinical findings: Multiple randomized controlled trials in adults with type 2 diabetes and metabolic syndrome have shown that berberine at 900–1,500mg daily, taken over 8–16 weeks, produces meaningful reductions in fasting blood glucose, postprandial blood glucose, and HbA1c. Studies have also documented reductions in LDL cholesterol and triglycerides with berberine taken alone (see Zhang et al., 2019, in the Citation List). Effect sizes on glucose markers are clinically meaningful — comparable in one head-to-head trial to metformin (Yin et al., 2008) — though direct comparisons remain limited across the broader literature and pharmaceutical-level outcomes should not be assumed.

Practical application: The standard studied dosage is 500mg taken two to three times daily with meals, totaling 1,000–1,500mg per day. Taking berberine with food appears to improve tolerability and may optimize absorption. Because berberine can cause GI symptoms — nausea, bloating, loose stools — starting at a lower dose (500mg once daily) and titrating up over one to two weeks is advisable. Do not exceed 1,500mg daily without medical supervision.

Dietary Fiber & Resistant Starch (Glucose Response Modulation)

Evidence grade: High Evidence

Mechanism: Soluble and fermentable dietary fibers — including beta-glucan from oats, resistant starch from legumes and underripe bananas, and inulin from chicory and onion — slow gastric emptying and reduce the rate at which glucose enters the bloodstream after a meal. In the colon, these fibers are fermented by gut bacteria into short-chain fatty acids (SCFAs), particularly butyrate and propionate, which improve insulin sensitivity and support GLP-1 secretion — a hormone that further moderates blood sugar response.

Clinical findings: Research in adults with type 2 diabetes and insulin resistance shows that consistent intake of 10–20g of fermentable fiber daily is associated with reductions in fasting glucose and postprandial glucose spikes, as well as modest HbA1c improvements over 8–12 weeks. Effect sizes are dose-dependent and show more variability than berberine trials, partly because individual gut microbiome composition affects how much SCFA is produced from a given fiber source.

Practical application: Target 25–38g of total dietary fiber per day from whole food sources, with at least 10–15g coming from fermentable types. Oats, lentils, beans, cooked-and-cooled rice or potatoes (which form resistant starch), Jerusalem artichokes, and green bananas are practical sources. If supplementing with isolated fibers (psyllium, inulin, partially hydrolyzed guar gum), start at 5g per day and increase gradually to avoid GI distress. Always pair increased fiber intake with increased water consumption.

Berberine + Gut Microbiome Modulation (Synbiotic Approach)

Evidence grade: Emerging Evidence

Mechanism: Berberine has been shown to selectively shift gut microbiome composition — reducing certain gram-negative bacteria associated with metabolic dysfunction while supporting species linked to improved glucose handling, including Akkermansia muciniphila and Faecalibacterium prausnitzii. This microbiome remodeling may amplify berberine's metabolic effects by increasing SCFA production and improving intestinal barrier integrity, which in turn reduces low-grade systemic inflammation — a key driver of insulin resistance. Combining berberine with a prebiotic or probiotic strategy (a synbiotic approach) is theorized to produce additive benefits through this pathway.

Clinical findings: This is an area of active investigation. Early-phase trials and mechanistic studies suggest that berberine's metabolic effects are partly mediated through gut microbiota changes, and that individuals with lower microbial diversity at baseline may respond less robustly to berberine alone.

Practical application: If pursuing berberine supplementation, supporting the gut environment with consistent intake of prebiotic-rich foods (onion, garlic, asparagus, oats, leeks) and fermented foods (kefir, yogurt, kimchi) is a reasonable complementary strategy grounded in the available mechanistic evidence. A dedicated synbiotic supplement is not required, and this combination approach should be discussed with a healthcare provider, particularly for anyone with a history of GI conditions.

Safety Considerations & Who Should Consult a Healthcare Provider

GI titration is important: the most commonly reported side effects of berberine are gastrointestinal — nausea, abdominal discomfort, bloating, loose stools, and constipation have all been reported. These effects are generally mild and transient, and most often occur when starting at full dose. Beginning at 500mg once daily with a meal and increasing to twice or three times daily over one to two weeks significantly reduces this risk.
Take with food, not on an empty stomach: berberine absorption and tolerability are both improved when taken alongside a meal rather than separately.
Dividing the daily dose across two to three meals also helps maintain more stable blood levels throughout the day and reduces the peak concentration that tends to cause GI side effects.
Berberine is a supplement, not a monitored drug: unlike prescription medications, berberine products are not standardized by the FDA for purity, potency, or manufacturing quality. Look for products that have been third-party tested (NSF, USP, or Informed Sport certified) and that clearly state the dose of berberine HCl per serving. Concentration and bioavailability vary significantly across commercial products.

Populations Requiring Medical Consultation

People taking diabetes medications (metformin, insulin, sulfonylureas, GLP-1 agonists): Berberine lowers blood glucose through overlapping mechanisms with several prescription diabetes drugs. Combining them without medical supervision raises the risk of hypoglycemia, blood sugar dropping too low. Dose adjustments to existing medications may be necessary, and this should only happen under a prescriber’s guidance.
People on cardiovascular medications or anticoagulants: Berberine has documented effects on heart rhythm and has been studied in heart failure populations. It may interact with antiarrhythmic drugs, beta-blockers, and blood thinners.
Anyone managing a cardiovascular condition should consult their cardiologist before starting berberine. People taking medications with narrow therapeutic windows: Berberine inhibits certain liver enzymes (notably CYP3A4 and CYP2D6) involved in drug metabolism. This means it can affect how the body processes a range of medications, including some antibiotics, cyclosporine, and certain psychiatric medications. If you take any drug where the dosing range is precise and consequences of over- or under-exposure are serious, speak with your pharmacist or prescriber before adding berberine.
People who are pregnant, breastfeeding, or trying to conceive: There is insufficient safety data on berberine use during pregnancy. Animal studies have raised concerns about potential effects on fetal development, and berberine is generally not recommended during pregnancy or lactation. Anyone trying to conceive should discuss this with their OB-GYN or reproductive endocrinologist, as berberine has also been studied for effects on ovulation, which could be relevant depending on the clinical context.

Medication Interactions

Berberine’s most clinically significant interactions involve medications that are metabolized by the CYP3A4 and CYP2D6 enzyme pathways in the liver, as berberine inhibits both. This means berberine can slow the breakdown of affected drugs, causing them to accumulate to higher levels in the body than intended.

Medications to be particularly mindful of include:

levothyroxine (thyroid hormone replacement)
cyclosporine (immunosuppressant)
certain antibiotics including clarithromycin and erythromycin
metformin and other glucose-lowering agents
warfarin and other anticoagulants
some antidepressants and antipsychotic medications

As a general precaution, if taking any prescription medication, berberine should be taken at least one to two hours before or after to minimize absorption interference. This timing approach does not eliminate interaction risk for enzyme-metabolized drugs and does not replace a conversation with a prescribing clinician.

Disclaimer: The information on this page is intended for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Berberine is a dietary supplement and has not been approved by the U.S. Food and Drug Administration (FDA) to diagnose, treat, cure, or prevent any disease or health condition. Individual results vary. This content is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting any supplement, particularly if you have a pre-existing medical condition, are taking prescription medications, or are pregnant or breastfeeding.

Frequently Asked Questions

Optional subeading

1. Can You Support Healthy Blood Sugar Naturally Without Medication?: Yes, certain dietary, lifestyle, and supplement strategies have meaningful clinical evidence behind them for supporting healthy glucose metabolism. Berberine, in particular, has been studied extensively in adults with prediabetes and type 2 diabetes, with consistent effects on fasting blood glucose, postprandial glucose, and HbA1c documented across multiple randomized controlled trials. Dietary patterns that prioritize fermentable fiber, adequate protein, and low glycemic load foods also produce measurable improvements in glucose response over time. That said, these approaches work best as part of a broader metabolic health strategy — they are not a replacement for prescribed medications in people who need them, and anyone managing a diagnosed blood sugar condition should work with their healthcare provider before making changes.
2. Who Should Talk to a Doctor Before Trying Berberine or a Blood Sugar Support Supplement?: Anyone currently taking a prescription medication for diabetes, heart conditions, thyroid function, or psychiatric health should speak with their doctor before starting berberine, because it can affect how those drugs are metabolized and may amplify or interfere with their effects. People who take blood thinners, immunosuppressants, or any medication with a narrow dosing window are also in this category. Pregnant women, those who are breastfeeding, and anyone trying to conceive should avoid berberine without explicit medical guidance, as safety data in those populations is insufficient. If you are unsure whether any of your current medications interact with berberine, your pharmacist is an excellent first resource — they can review your full medication list and flag any concerns before you start.
3. How Long Does It Take to See Results From Berberine or Dietary Changes for Blood Sugar?: Most clinical trials measuring blood sugar outcomes report statistically meaningful changes within 8 to 12 weeks of consistent daily use at an effective dose. Some individuals notice subjective improvements — like feeling fewer energy crashes after meals or reduced cravings — within the first two to four weeks, though these early changes reflect metabolic shifts that precede what shows up on lab work. HbA1c, which reflects average blood sugar over approximately three months, will not meaningfully change on shorter timelines regardless of what intervention is used. Results are cumulative and require sustained daily habits, not occasional use — skipping doses or reverting to high-glycemic eating patterns will slow or erase progress.
4. Does Blood Sugar Support Only Matter if You Have Diabetes?: No, blood sugar regulation affects everyone, and the research on glucose variability increasingly shows that even people without a diabetes diagnosis can experience meaningful health effects from how their blood sugar rises and falls throughout the day. Sustained high postprandial glucose spikes, poor insulin sensitivity, and chronically elevated fasting glucose are associated with fatigue, cognitive fog, increased hunger, weight gain, and long-term cardiovascular and metabolic risk — all of which can be present well before a clinical diagnosis. The dietary and supplement strategies studied for glucose support, including fiber intake, meal timing, and berberine, have documented benefits in metabolically healthy adults as well as those with identified dysfunction. Supporting stable blood sugar is relevant to metabolic wellness broadly, not only to disease management.
5. What Foods and Nutrients Are Most Studied for Blood Sugar and Glucose Balance?: Fermentable dietary fibers — including beta-glucan from oats, resistant starch from legumes and cooked-and-cooled starchy foods, and inulin from onion, garlic, and chicory — have consistent clinical evidence for reducing postprandial glucose spikes and improving insulin sensitivity over time. Protein, particularly at breakfast and earlier in the day, has been shown to blunt glucose response and support satiety signaling that helps regulate overall intake. Berberine is the most studied botanical compound in this category, with a well-characterized mechanism of action via AMPK activation that parallels some pharmaceutical approaches. Meal sequencing — eating vegetables and protein before carbohydrates — has emerging evidence for reducing the glucose peak from a given meal without changing what you eat. No single food acts as a fix; the pattern of eating across the day matters more than any individual item.
6. Does Blood Sugar Support Work the Same Way for Everyone?: No, and this is one of the most important things the research makes clear. Individual response to both dietary interventions and berberine supplementation varies substantially based on baseline gut microbiome composition, existing insulin sensitivity, genetics, body weight, sleep quality, stress levels, and what other medications a person is taking. People with more significant metabolic dysfunction at baseline — higher fasting glucose, more pronounced insulin resistance — tend to show larger and more consistent effects in clinical trials, while those who are metabolically healthy may see subtler changes. This biological variability is normal and does not mean an approach is failing; it means the intervention needs to be evaluated in the context of the individual. Working with a clinician who can track relevant biomarkers over time is the most reliable way to assess whether a given strategy is actually working for you.

Primary Source Evidence Evidence Base For This Article

This analysis synthesizes findings from 8 peer-reviewed sources on berberine specifically (2 review articles plus 6 primary randomized controlled trials/mechanistic studies), all evaluated for berberine-alone effects. Supplementary background context comes from 5 government/health-system reference sources and 2 registered clinical trials (one confirmed, one flagged for verification). All primary research is published in PubMed-indexed journals with DOI identifiers.

What We're Still Learning: Current Research Gaps

Current Research Gaps Optimal dosing protocols for non-diabetic populations:

Nearly all berberine RCT data comes from adults with confirmed type 2 diabetes, prediabetes, or metabolic syndrome. We don’t yet have well-powered trials establishing whether and at what dose berberine produces meaningful glucose benefits in metabolically healthy adults — a gap that matters given how widely the supplement is now used for general wellness.

Long-term safety beyond 6 months:

Most berberine clinical trials run 8–16 weeks. There is very limited data on what happens with sustained use over 6 months to several years — including whether effects plateau, whether the gut microbiome adapts in ways that reduce efficacy, and whether any long-term safety signals emerge that shorter trials wouldn’t capture. Berberine bioavailability and formulation: Berberine has notoriously low oral bioavailability due to poor intestinal absorption and rapid metabolism. Newer formulations — including dihydroberberine and berberine phytosome complexes — are being studied for improved uptake, but comparative clinical evidence on whether these produce meaningfully better outcomes than standard berberine HCl is still limited.

Microbiome-mediated response variability:

Research increasingly suggests that berberine’s metabolic effects are partly mediated through gut bacteria — specifically species that produce short-chain fatty acids and support intestinal barrier integrity. What we don’t yet understand is whether baseline microbiome profiling could predict who will respond well versus poorly, which would have significant implications for personalized supplementation guidance. Sex-specific and hormonal interactions: Most berberine trials aggregate results across sexes, and few specifically examine how hormonal status — menstrual cycle phase, perimenopause, menopause, or the presence of conditions like polycystic ovary syndrome — affects response. Early data suggests berberine may influence insulin resistance and ovulation in women with PCOS, but this remains an underdeveloped area of research that warrants dedicated trials.

Primary Source Evidence

Briefly describe the evidence base for this article — number of studies, study types, and where they are indexed.

📚 View Full Citation List (11 studies)

Berberine: Botanical occurrence, traditional uses, extraction methods, and relevance in cardiovascular, metabolic, hepatic, and renal disorders (2018). Neag MA, Mocan A, Echeverría J, Pop RM, Bocsan CI, Crișan G, Buzoianu AD. Frontiers in Pharmacology. doi:10.3389/fphar.2018.00557
Berberine, a herbal metabolite in the metabolic syndrome: The risk factors, course, and consequences of the disease (2022). Och A, Och M, Nowak R, Podgórska D, Podgórski R. Molecules. doi:10.3390/molecules27041351
Efficacy of berberine in patients with type 2 diabetes mellitus (2008). Yin J, Xing H, Ye J. Metabolism. doi:10.1016/j.metabol.2008.01.013
Effect of berberine on cardiovascular disease risk factors: A mechanistic randomized controlled trial (2021). Zhao JV, Yeung WF, Chan YH, Vackova D, Leung JYY, Ip DKM, Zhao J, Ho WK, Tse HF, Schooling CM. Nutrients. doi:10.3390/nu13082550
Berberine is an insulin secretagogue targeting the KCNH6 potassium channel (2021). Zhao MM, Lu J, Li S, Wang H, Cao X, Li Q, Shi TT, Matsunaga K, Chen C, Huang H, et al.. Nature Communications. doi:10.1038/s41467-021-25952-2
Modulation of glucagon-like peptide-1 release by berberine: In vivo and in vitro studies (2010). Yu Y, Liu L, Wang X, Liu X, Liu X, Xie L, Wang G. Biochemical Pharmacology. doi:10.1016/j.bcp.2009.11.017
Efficacy and safety of berberine alone or combined with statins for the treatment of hyperlipidemia: A systematic review and meta-analysis of randomized controlled clinical trials (2019). Zhang LS, Zhang JH, Feng R, Jin XY, Yang FW, Ji ZC, Zhao MY, Zhang MY, Zhang BL, Li XM. The American Journal of Chinese Medicine. doi:10.1142/S0192415X19500393
Berberine versus placebo for the prevention of recurrence of colorectal adenoma: A multicentre, double-blinded, randomised controlled study (2020). Chen YX, Gao QY, Zou TH, Wang BM, Liu SD, Sheng JQ, Ren JL, Zou XP, Liu ZJ, Song YY, et al.. The Lancet Gastroenterology & Hepatology. doi:10.1016/S2468-1253(19)30409-1
Berberine (In LiverTox: Clinical and Research Information on Drug-Induced Liver Injury) (2020). National Institute of Diabetes and Digestive and Kidney Diseases. LiverTox, National Library of Medicine. Full text
In the News: Berberine (2023). National Center for Complementary and Integrative Health. U.S. Department of Health and Human Services. Full text
Berberine (2024). Memorial Sloan Kettering Cancer Center. Integrative Medicine. Full text

Brooke Danielson

Brooke Ely Danielson is the Director of Editorial and Content at HUM Nutrition. She is certified in plant-based nutrition through the T. Colin Campbell Center of Nutrition Studies via Cornell University. Danielson is passionately plant-based, an art lover, runner, skier, bookworm, world traveler and a dedicated Achilles International guide.

Share this research

Email Copy Link